Jubilant Pharma completes stake sale in Sofie Biosciences
Merger with Trilantic Capital Partners leads to strategic disinvestment Jubilant Pharma (JPL), has finalised the sale of its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Trilantic Capital Partners
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…